andiolol for improved outcome in cardiac arrest

Phase 1

• Conditions: out-of-hospital cardiac arrest; Therapeutic area: Not possible to specify

• Registration Number: EUCTR2020-003661-19-AT
• Lead Sponsor: Medical University of Vienna

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-31
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

OHCA patient, more or equal than 18 years of age
Initial shockable rhythm (VF or pVT) as determined by the EMS team
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range 26
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 6

Exclusion Criteria

Initial rhythm pEA, asystole or unknown
Age > 85a
Severe head trauma or acute active bleeding
Known allergy or insensitivity to landiolol or another beta-blocker
No treatment capacity at the emergency department of the Medical University of Vienna

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified